Publication: Evaluación de los niveles de osteocalcina, osteopontina y osteoprotegerina en cultivos de células madre mesenquimales de diversos orígenes: Estudio piloto.
Loading...
Official URL
Full text at PDC
Publication Date
2013
Authors
Advisors (or tutors)
Editors
Journal Title
Journal ISSN
Volume Title
Publisher
Citations
Exportar
Abstract
Description
UCM subjects
Unesco subjects
Keywords
Citation
1 Magallanes Fabián M, Carmona Rodríguez B, Álvarez Pérez MA. Aislamiento y caracterización parcial de células madre de pulpa dental. Revista Odontológica Mexicana. 2010; 14 (1): 15-20.
2 Friedenstein AJ, Deriglasova UF, Kulagina NN, Panasuk AF, Rudakowa SF, Luria EA et al. Precursors for fibroblasts in different populations of hematopoietic cells as detected
by the in vitro colony assay method. Exp Hematol. 1974; 2(2): 83–92.
3 Razzouk S, Schoor R. Mesenchymal stem cells and their challenges for bone regeneration and osseointegration. Journal of periodontology. 2011.
4 López-Laguna M, Saldaña-Díaz A, Rafael L, Rodríguez-Altónaga JA, Ramos J, García P et al. Marcaje de células madre mesenquimales derivadas de tejido adiposo para su
localización y seguimiento mediante RM en terapias de regeneración ósea. Rev esp cir ortop traumatol. 2011; 55 (5): 369—77.
5 Bahrambeigi V, Salehi R, Hashemibeni B, Esfandiari E. Transcriptomic comparison of osteopontin, osteocalcin and core binding factor 1 genes between human adipose
derived differenciated osteoblasts and native osteoblasts. Adv Biomed Res. 2012; 1: 8.
6 Patti A, Gennari L, Merlotti D, Dotta F, Nuti R. Endocrine actions of osteocalcin. International Journal of Endocrinology. 2013.
7 Viegas C, Simes D, Williamson M, Cavaco S, Laizé V, Price P et al. Sturgeon Osteocalcin Shares Structural Features with Matrix Gla Protein: Evolutionary Relationship and
Functional Implications. The J Biol. Chem. 2013.
8 Jorquera R, Gonzalez J, Gutierrez S, Jorquera O, Rivera S. Osteocalcina en el fluido crevicular de pacientes con periodontitis crónica progresiva. Periodontia. 2009; 19 (4):
89-93.
9 İncesoy-Özdemir S, Şahin G, Bozkurt C, Ceyda A, Balkaya E, Ertem U. The relationship between cerebrospinal fluid osteopontin level and central nervous system involvement
in childhood acute leukemia. The Turkish Journal of Pediatrics. 2013; 55: 42- 9.
10 Rao G, Du L, Chen Q. Osteopontin, a possible modulator of cancer stem cells and their malignant niche. OncoImmunology. 2013; 2.
11 Li X, Qi Y, Ma X, Huang F, Guo H, Jiang Xet al. Chemokine (C-C Motif) Ligand 20, a Potential Biomarker for Graves’ Disease, Is Regulated by Osteopontin. PLoS ONE. 2013; 8(5).
12 Pateinakis, Papagianni A, Douma S, Efstriatiadis G, Memmos D. Associations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic
hemodialysis patients. BMC Nephrology. 2013; 14: 122.
13 Guo C, Hu F, Zhang S, Wang Y, Liu H. Association between osteoprotegerin gene polymorphisms and cardiovascular disease in type 2 diabetic patients. Genetics and
Molecular Biology. 2013; 36 (2): 177-82.
14 Zhou S, Fang X, Xin H, Li W, Qiu H, Guan S. Osteoprotegerin Inhibits Calcification of Vascular Smooth Muscle Cell via Down Regulation of the Notch1-RBP-Jκ/Msx2
Signaling Pathway. PLoS ONE. 2013; 8(7).
15 Weiss RM, Lund DD, Chu Y, Brooks RM, Zimmerman KA, El Accaoui R et al.Osteoprotegerin Inhibits Aortic Valve Calcification and Preserves Valve Function in
Hypercholesterolemic Mice. PLoS ONE. 2013; 8(6).
16 Jandal K, Krzanowski M, Chowaniec E, Kuśnierz-Cabala B, Dumnicka P, Kraśniak A et al. Osteoprotegerin as a marker of cardiovascular risk in patients on peritoneal dialysis.
Pol Arch Med Wewn. 2013; 123 (4): 149-55.
17 Palumbo S, Li W-J. Osteoprotegerin Enhances Osteogenesis of Human Mesenchymal Stem Cells. Tissue engineering. 2013; 0 (0): 1-12.
18 Queiroz AC, Nóbrega PB, Oliveira FS, Novaes AB Jr, Taba M Jr, Palioto DB et al. Treatment of intrabony defects with anorganic bone matrix/p-15 or guided tissue regeneration in patients with aggressive periodontitis. Braz Dent J. 2013; 24(3): 204-12.
19 Rolim Filho EL, Larrazabal MC, Costa Júnior LF, Santos SM, Santos RM, Aguiar JL. Effect of autologous stem cells on regenerated bone during distraction osteogenesis by
Ilizarov technique in the radius of dogs: histomorphometric analysis. Acta Cir Bras. 2013; 28(8):574-81.
20 Woo M, Seong D, Hee K, Ryung H, Keun I, Hyang J et al. Human bone marrowderived mesenchymal stem cell gene expression patterns vary with culture conditions.
Blood Res. 2013; 48(2): 107–14.
21 Giulani N, Lisignoli G, Magnani M, Racano C, Bolzoni M, Palma BD et al. New Insights into Osteogenic and Chondrogenic Differentiation of Human Bone Marrow
Mesenchymal Stem Cells and Their Potential Clinical Applications for Bone Regeneration in Pediatric Orthopaedics. Stem Cells Int. 2013.
22 Arévalo JA, Páez DM, Rodríguez VM. Células madre mesenquimales: características biológicas y aplicaciones clínicas. NOVA - PUBLICACIÓN CIENTÍFICA EN CIENCIAS
BIOMÉDICAS. 2007; 5 (8): 177-84.
23 Zheng YH, Xiong W, Su K, Kuang SJ, Zhang ZG. Multilineage differentiation of human bone marrow mesenchymal stem cells in vitro and in vivo. Exp Ther Med. 2013; 5(6): 1576–80.
24 Jones GN, Moschidou D, Lay K, Abdulrazzak H, Vanleene M, Shefelbine SJ et al. Upregulating CXCR4 in human fetal mesenchymal stem cells enhances engraftment and bone mechanics in a mouse model of osteogenesis imperfecta. Stem Cells Transl Med. 2012; 1(1): 70-8.